EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

New Horizons: Artificial Intelligence Tools for Managing Osteoporosis

Hans Peter Dimai iD

The Journal of Clinical Endocrinology & Metabolism · 10.03.2023 · 108 (4) · 775-783

DOI: 10.1210/clinem/dgac702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 08.12.2022. Verfasst von Hans Peter Dimai. Beteiligte Einrichtung: Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Osteoporosis, Osteoporotic Fractures. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical University of Graz, Austria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporosis is a disease characterized by low bone mass and microarchitectural deterioration leading to increased bone fragility and fracture risk. Typically, osteoporotic fractures occur at the spine, hip, distal forearm, and proximal humerus, but other skeletal sites may be affected as well. One of the major challenges in the management of osteoporosis lies in the fact that although the operational diagnosis is based on bone mineral density (BMD) as measured by dual x-ray absorptiometry, the majority of fractures occur at nonosteoporotic BMD values. Furthermore, osteoporosis often remains undiagnosed regardless of the low severity of the underlying trauma. Also, there is only weak consensus among the major guidelines worldwide, when to treat, whom to treat, and which drug to use. Against this background, increasing efforts have been undertaken in the past few years by artificial intelligence (AI) developers to support and improve the management of this disease. The performance of many of these newly developed AI algorithms have been shown to be at least comparable to that of physician experts, or even superior. However, even if study results appear promising at a first glance, they should always be interpreted with caution. Use of inadequate reference standards or selection of variables that are of little or no value in clinical practice are limitations not infrequently found. Consequently, there is a clear need for high-quality clinical research in this field of AI. This could, eg, be achieved by establishing an internationally consented “best practice framework” that considers all relevant stakeholders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisOsteoporotic FracturesHumansArtificial IntelligenceRisk AssessmentBone DensityAbsorptiometry, Photon

Stichwörter der Autor:innen

artificial intelligencefracture riskopportunistic diagnosisosteoporosis

Autor:innen und Institutionen

  • Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

ORCID-Profile: Hans Peter Dimai

Förderung

  • Medical University of Graz, Austria

Zitieren

APA

Dimai, H. P. (2023). New Horizons: Artificial Intelligence Tools for Managing Osteoporosis. The Journal of Clinical Endocrinology & Metabolism, 108(4), 775-783. https://doi.org/10.1210/clinem/dgac702

Vancouver

Dimai HP. New Horizons: Artificial Intelligence Tools for Managing Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 2023;108(4):775-783. doi:10.1210/clinem/dgac702

BibTeX
@article{Dimai2023,
  author = {Dimai, Hans Peter},
  title = {New Horizons: Artificial Intelligence Tools for Managing Osteoporosis},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  volume = {108},
  number = {4},
  pages = {775--783},
  doi = {10.1210/clinem/dgac702}
}
Kostenlos starten →